High-sensitivity assays to detect cardiac troponin have been gaining favor among some cardiologists and labs beyond their role in diagnosing myocardial infarction to further stratify patients’ risk of poor cardiac outcomes, even those with stable disease. However, whether clinicians should use these values to implement more aggressive interventions remains in…